During the past decade, Universitätskliniken des Saarlandes / Medizinische Klinik und Poliklinik, Innere Medizin V conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 6 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitätskliniken des Saarlandes / Medizinische Klinik und Poliklinik, Innere Medizin V" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Actelion" with 3 trials sponsored, "United Therapeutics" with 2 trials sponsored, "Pfizer" with 1 trials sponsored and "Pneumonia Research Network on Genetic Resistance and Susceptibility for the Evolution of Severe Seps" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätskliniken des Saarlandes / Medizinische Klinik und Poliklinik, Innere Medizin V" #1 collaborator was "Charite University, Berlin, Germany" with 1 trials as a collaborator, "German Federal Ministry of Education and Research" with 1 trials as a collaborator, "Jena University Hospital" with 1 trials as a collaborator, "University Medicine Greifswald" with 1 trials as a collaborator and "University of Giessen" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Universitätskliniken des Saarlandes / Medizinische Klinik und Poliklinik, Innere Medizin V" are "Pulmonary Arterial Hypertension" (4 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Cardiovascular Diseases" (2 trials), "Connective Tissue Diseases" (2 trials) and "Familial Primary Pulmonary Hypertension" (2 trials). Many other conditions were trialed in "Universitätskliniken des Saarlandes / Medizinische Klinik und Poliklinik, Innere Medizin V" in a lesser frequency.

Most popular intervention types in "Universitätskliniken des Saarlandes / Medizinische Klinik und Poliklinik, Innere Medizin V" are "Drug" (10 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (2 trials), "Carboplatin" (2 trials), "Paclitaxel" (2 trials), "Placebo" (2 trials) and "Ralinepag" (2 trials). Other intervention names were less common.

The vast majority of trials in "Universitätskliniken des Saarlandes / Medizinische Klinik und Poliklinik, Innere Medizin V" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Universitätskliniken des Saarlandes / Medizinische Klinik und Poliklinik, Innere Medizin V". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 7 completed trials in Universitätskliniken des Saarlandes / Medizinische Klinik und Poliklinik, Innere Medizin V, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Universitätskliniken des Saarlandes / Medizinische Klinik und Poliklinik, Innere Medizin V, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".